As of 12 July, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18337deaths.
Vaccines- Governments, foundations and manufacturers have offered contributions of vaccines, ancillary products (such as syringes and safety boxes) and finances to support the donation initiative
Emerging data on Oseltamivir resistance of the virus is also worrying. Geographical distribution of oseltamivir resistance by the WHO regions (as of 14 July 2010) shows high prevalence of resistant virus strains in European, Western Pacific and North American regions (PDF)
Vaccines- Governments, foundations and manufacturers have offered contributions of vaccines, ancillary products (such as syringes and safety boxes) and finances to support the donation initiative
Emerging data on Oseltamivir resistance of the virus is also worrying. Geographical distribution of oseltamivir resistance by the WHO regions (as of 14 July 2010) shows high prevalence of resistant virus strains in European, Western Pacific and North American regions (PDF)
Interestingly, 24% of the resistant cases were seen in patients who had taken post exposure prophylaxis.